Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on 8-K, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Ex
of this Current Report on Form 8-K, including Exhibit 99.2 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release dated March 5, 2026 99.2 Silence Therapeutics plc corporate prese